Literature DB >> 3842600

A case for human tumor-suppressor genes.

E J Stanbridge.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 3842600     DOI： 10.1002/bies.950030605

Source DB:  PubMed          Journal:  Bioessays        ISSN： 0265-9247            Impact factor:   4.345


× No keyword cloud information.
  7 in total

Review 1.  Frontiers in mammalian cell culture.

Authors:  W L McKeehan; D Barnes; L Reid; E Stanbridge; H Murakami; G H Sato
Journal:  In Vitro Cell Dev Biol       Date:  1990-01

2.  The normal human H-ras1 gene can act as an onco-suppressor.

Authors:  A Spandidos; N M Wilkie
Journal:  Br J Cancer Suppl       Date:  1988-12

3.  Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.

Authors:  A G Geiser; C J Der; C J Marshall; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas.

Authors:  S Y Liao; C Brewer; J Závada; J Pastorek; S Pastorekova; A Manetta; M L Berman; P J DiSaia; E J Stanbridge
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

5.  Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.

Authors:  M C Goyette; K Cho; C L Fasching; D B Levy; K W Kinzler; C Paraskeva; B Vogelstein; E J Stanbridge
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

6.  Identification of a cell-surface glycoprotein associated with normal mammary and extramammary epithelial cells.

Authors:  S A Imam; M R Stampfer; A Yilmaz; C R Taylor
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

7.  Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.

Authors:  P J Saxon; E S Srivatsan; E J Stanbridge
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.